Amberly Hunter received her B.S. in Biology with a Minor in Public Health from Sam Houston State University in 2020. After graduating, she joined Emory University School of Medicine’s Vaccine and Treatment Evaluation Unit as a research specialist under the direction of Dr. Evan J. Anderson, MD where she handled and processed human biological samples for Phase 1 – Phase 3 clinical trial research with a primary focus on SARS-CoV-2 and Respiratory Syncytial Virus (RSV) vaccine efficacy and disease surveillance. She transferred to the Paiardini lab in January of 2022 to expand on her knowledge of HIV utilizing SIV infected non-human primates as a comparative model. In September of 2022, she transitioned into the role of lead research specialist, and she is currently pursuing a Master’s in Clinical Mental Health Counseling in her free time.